The Effects of the Digital Platform Support Monitoring and Reminder Technology for Mild Dementia (SMART4MD) for People With Mild Cognitive Impairment and Their Informal Carers: Protocol for a Pilot Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Many countries are witnessing a trend of growth in the number and proportion of older adults within the total population. In Europe, population aging has had and will continue to have major social and economic consequences. This is a fundamentally positive development where the added life span is of great benefit for both the individual and the society. Yet, the risk for the individual to contract noncommunicable diseases and disability increases with age. This may adversely affect the individual's ability to live his or her life in the way that is desired. Cognitive conditions constitute a group of chronic diseases that predominantly affects older people. Recent technology advancements can help support the day-to-day living activities at home for people with cognitive impairments. OBJECTIVE: A digital platform (Support Monitoring and Reminder for Mild Dementia; SMART4MD) is created to improve or maintain the quality of life for people with mild cognitive impairment (PwMCI) and their carers. The platform will provide reminders, information, and memory support in everyday life, with the purpose of giving structure and lowering stress. In the trial, we will include participants with a diagnosed neurocognitive disorder as well as persons with an undiagnosed subjective memory problem and cognitive impairment, that is, 20 to 28 points on the Mini-Mental State Examination. METHODS: A pragmatic, multicenter RCT is being conducted in Spain, Sweden, and Belgium. The targets for recruitment are 1200 dyads-split into an intervention group and a control group that are in usual care. Intervention group participants will be provided with a data-enabled computer tablet with the SMART4MD app. Its core functionalities, intended to be used daily at home, are based on reminders, cognitive supporting activities, and sharing health information. RESULTS: Inclusion of participants started in December 2017, and recruitment is expected to end in February 2019. Furthermore, there will be 3 follow-up visits at 6, 12, and 18 months after the baseline visit. CONCLUSIONS: This RCT is expected to offer benefits at several levels including in-depth knowledge of the possibilities of introducing a holistic multilayered information and communication technology solution for this group. SMART4MD has been developed in a process involving the structured participation of PwMCI, their informal carers, and clinicians. The adoption of SMART4MD faces the challenge of this age group's relative unfamiliarity with digital devices and services. However, this challenge can also be an opportunity for developing a digital device tailored to a group at risk of digital exclusion. This research responds to the wider call for the development of digital devices which are accessible and affordable to older people and this full scale RCT can hopefully serve as a model for further studies in this field. TRIAL REGISTRATION: ClinicalTrials.gov NCT03325699; https://clinicaltrials.gov/ct2/show/NCT03325699. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/13711.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Whoqol Group (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00009-4 · Cited by 3,802
Bédard, M., Molloy, D. W., Squire, L., Dubois, S., Lever, J. A., & O'Donnell, M. (2001) · The Gerontologist · doi:10.1093/geront/41.5.652 · Cited by 1,691
Assessing Quality of Life in Older Adults With Cognitive Impairment
Logsdon, R. G., Gibbons, L. E., McCurry, S. M., & Teri, L. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200205000-00016 · Cited by 1,381 · cited 1×
“Health related quality of life of PwMCI will be measured using the total score of the QoL-AD questionnaire [33,38,39].”
MethodDonepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
Caregiver burden for informal caregivers of patients with dementia: a systematic review
Chiao, C. ‐., Wu, H. ‐., & Hsiao, C. ‐. (2015) · International Nursing Review · doi:10.1111/inr.12194 · Cited by 829
Sachdev, P. S., Lipnicki, D. M., Kochan, N. A., Crawford, J. D., Thalamuthu, A., Andrews, G., Brayne, C., Matthews, F. E., Stephan, B. C. M., Lipton, R. B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142388 · Cited by 380
Adherence: Comparison of Methods to Assess Medication Adherence and Classify Nonadherence
Hansen, R. A., Kim, M. M., Song, L., Tu, W., Wu, J., & Murray, M. D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l496 · Cited by 274 · cited 1×
“The dose/pill count is the number of pills or doses taken divided by the number of pills or doses prescribed, multiplied by 100 (expressed as a percentage) [40,41].”
BackgroundA systematic review of medication non-adherence in persons with dementia or cognitive impairment
Smith, D., Lovell, J., Weller, C., Kennedy, B., Winbolt, M., Young, C., & Ibrahim, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170651 · Cited by 242
Medication Adherence in Older Adults With Cognitive Impairment: A Systematic Evidence-Based Review
Campbell, N. L., Boustani, M. A., Skopelja, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.04.004 · Cited by 206 · cited 1×
“If we consider that in people with dementia, the treatment adherence is between 44% and 99% [35,36], and assuming the less prevalence (44%), which we want to increase by 10%, with a power of 0.”
Background
Cited by
Guzman-Parra, J., Barnestein-Fonseca, P., Guerrero-Pertiñez, G., Anderberg, P., Jimenez-Fernandez, L., Valero-Moreno, E., Goodman-Casanova, J. M., Cuesta-Vargas, A., Garolera, M., Quintana, M., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/17253 · Cited by 69
“More detailed information on the trial is available in the published protocol [18].”
Self-citationArnold, A., Kolody, S., Comeau, A., & Miguel Cruz, A. (2024) · Disability and Rehabilitation: Assistive Technology · doi:10.1080/17483107.2022.2065369 · Cited by 59
Aboye, G. T., Vande Walle, M., Simegn, G. L., & Aerts, J.-M. (2023) · Digital Health · doi:10.1177/20552076231180972 · Cited by 31
Relationship between digital exclusion and cognitive impairment in Chinese adults
Liu, X., Wang, X., Zhang, H., Pei, M., & Li, N. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1194348 · Cited by 16
“On the other hand, cognitive impairment itself can be a barrier to digital inclusion, as it can make it more difficult for individuals to learn new digital skills and use digital technologies effectively (Anderberg et al., 2019; Gerritzen et al., 2023).”
Background
Metadata
- Authors
- Anderberg, P., Barnestein-Fonseca, P., Guzman-Parra, J., Garolera, M., Quintana, M., Mayoral-Cleries, F., Lemmens, E., & Sanmartin Berglund, J.
- Venue
- JMIR Research Protocols
- Publisher
- JMIR Publications Inc.
- Published
- 2019-06-21
- Volume
- 8
- Issue
- 6
- Pages
- e13711
- ISSN
- 1929-0748 (ISSN-L)
- OpenAlex
- W2945162507
- Cited by
- 28
- References
- 15
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.